| The cost of concordance with opiate substitution treatment guidelines. | |
| | |
MedLine Citation:
|
PMID: 20598830 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The Multisite Opiate Substitution Treatment study compared four opioid substitution programs that were highly concordant with clinical practice guidelines to four programs that were less concordant. Program staff were surveyed, and consenting new patients from highly concordant (n = 164) and less-concordant programs (n = 91) were assessed. After 12 months, treatment of new clients of highly staffed, guideline concordant sites cost $10,252, which is significantly more than the $6,476 cost at less-concordant programs (p < .01). Clients at highly concordant sites received significantly more group visits (M = 37.0 vs. 13.1, p < .01) but fewer dosing visits. There were no significant differences in medical care costs. Opioid substitution therapy was effective at reducing heroin use, especially at sites that were highly concordant with treatment guidelines. Annual mortality was 3.0% and did not differ by type of care. Preference-based quality of life significantly improved only at highly concordant sites. |
| | |
Authors:
|
Paul G Barnett; Jodie A Trafton; Keith Humphreys |
Publication Detail:
|
Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S. Date: 2010-07-03 |
Journal Detail:
|
Title: Journal of substance abuse treatment Volume: 39 ISSN: 1873-6483 ISO Abbreviation: J Subst Abuse Treat Publication Date: 2010 Sep |
Date Detail:
|
Created Date: 2010-07-27 Completed Date: 2010-11-22 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8500909 Medline TA: J Subst Abuse Treat Country: United States |
Other Details:
|
Languages: eng Pagination: 141-9 Citation Subset: IM |
Copyright Information:
|
Published by Elsevier Inc. |
Affiliation:
|
VA Health Economics Resource Center (HERC), VA Palo Alto Health Care System, Menlo Park, CA 94025, USA. paul.barnett@va.gov |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cost-Benefit Analysis Delivery of Health Care / utilization Female Guideline Adherence Health Care Costs* Humans Male Methadone / therapeutic use Middle Aged Opioid-Related Disorders / drug therapy*, psychology Practice Guidelines as Topic |
| Chemical | |
Reg. No./Substance:
|
76-99-3/Methadone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: N...
Next Document: Comparison of opiate-primary treatment seekers with and without alcohol use disorder.